X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1085) 1085
Publication (78) 78
Book Review (17) 17
Book Chapter (12) 12
Magazine Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (872) 872
male (770) 770
index medicus (583) 583
middle aged (337) 337
aged (323) 323
prostatic hyperplasia - drug therapy (260) 260
adrenergic alpha-1 receptor antagonists - therapeutic use (256) 256
animals (255) 255
female (248) 248
treatment outcome (215) 215
urology & nephrology (203) 203
adrenergic alpha-1 receptor antagonists (195) 195
tamsulosin (192) 192
adult (191) 191
benign prostatic hyperplasia (174) 174
adrenergic alpha-1 receptor antagonists - adverse effects (165) 165
pharmacology & pharmacy (160) 160
sulfonamides - adverse effects (152) 152
adrenergic alpha-antagonists - adverse effects (142) 142
adrenergic alpha-1 receptor antagonists - administration & dosage (130) 130
rats (129) 129
sulfonamides - therapeutic use (129) 129
adrenergic alpha-antagonists - therapeutic use (128) 128
drug therapy, combination (119) 119
prospective studies (118) 118
prostatic hyperplasia - complications (112) 112
double-blind (107) 107
efficacy (106) 106
aged, 80 and over (102) 102
ophthalmology (98) 98
dose-response relationship, drug (97) 97
prostate (95) 95
iris diseases - chemically induced (94) 94
double-blind method (90) 90
medicine & public health (90) 90
adrenergic alpha-antagonists - pharmacology (88) 88
drug therapy (87) 87
urology (86) 86
lower urinary tract symptoms - drug therapy (85) 85
management (85) 85
receptors, adrenergic, alpha-1 - metabolism (85) 85
men (82) 82
surgery (76) 76
care and treatment (74) 74
risk factors (74) 74
blood pressure - drug effects (73) 73
urinary-tract symptoms (73) 73
adrenergic alpha-1 receptor antagonists - pharmacology (72) 72
analysis (72) 72
doxazosin (72) 72
intraoperative complications (71) 71
hypertrophy (69) 69
time factors (69) 69
adrenergic beta-antagonists - therapeutic use (67) 67
tamsulosin hydrochloride (67) 67
syndrome (66) 66
quality of life (63) 63
lower urinary tract symptoms (62) 62
sulfonamides - administration & dosage (62) 62
neurosciences (60) 60
alfuzosin (59) 59
prazosin - pharmacology (59) 59
prazosin - therapeutic use (58) 58
cardiac & cardiovascular systems (57) 57
hypertension (57) 57
prostatic hyperplasia - physiopathology (56) 56
hypertension - drug therapy (55) 55
mice (55) 55
medicine, general & internal (54) 54
psychiatry (53) 53
receptors, adrenergic, alpha-1 - drug effects (51) 51
receptors, adrenergic, alpha-1 - physiology (50) 50
doxazosin - therapeutic use (49) 49
heart failure - drug therapy (49) 49
indoles - therapeutic use (49) 49
prazosin - analogs & derivatives (49) 49
phacoemulsification (48) 48
pupil - drug effects (48) 48
abridged index medicus (47) 47
clinical trials (47) 47
prazosin (47) 47
rats, sprague-dawley (47) 47
heart failure (46) 46
therapy (45) 45
internal medicine (44) 44
silodosin (44) 44
young adult (44) 44
adolescent (43) 43
randomized controlled trials as topic (43) 43
adrenergic alpha-antagonists - administration & dosage (42) 42
adrenergic receptors (42) 42
retrospective studies (42) 42
safety (42) 42
article (41) 41
incidence (41) 41
lower urinary tract symptoms - etiology (41) 41
follow-up studies (40) 40
research (40) 40
adrenergic beta-antagonists - pharmacology (39) 39
carvedilol (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1042) 1042
Russian (15) 15
German (11) 11
Japanese (10) 10
Chinese (6) 6
French (5) 5
Spanish (4) 4
Romanian (2) 2
Dutch (1) 1
Hebrew (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brachytherapy, ISSN 1538-4721, 05/2018, Volume 17, Issue 3, pp. 537 - 543
Journal Article
Alcoholism: Clinical and Experimental Research, ISSN 0145-6008, 05/2015, Volume 39, Issue 5, pp. 808 - 817
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 6, pp. 1003 - 1012
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 09/2013, Volume 170, Issue 9, pp. 1003 - 1010
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 2, pp. 228 - 243
Abstract Background Several drugs are approved for the treatment of lower urinary tract symptoms (LUTS) in men, but these are mostly used by clinicians as... 
Urology | Muscarinic antagonists | Prostatic hyperplasia | 5α-reductase inhibitors | Lower urinary tract symptoms | Adrenergic α1-receptor antagonists | TOLTERODINE EXTENDED-RELEASE | OVERACTIVE BLADDER SYMPTOMS | PHOSPHODIESTERASE-5 INHIBITOR | RANDOMIZED CONTROLLED-TRIAL | BENIGN PROSTATIC HYPERPLASIA | ALPHA-BLOCKER | 5 alpha-reductase inhibitors | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | COMBINED ORAL-THERAPY | Adrenergic alpha-receptor antagonists | TREATMENT SATISFACTION | ERECTILE DYSFUNCTION | Phosphodiesterase 5 Inhibitors - adverse effects | Humans | Muscarinic Antagonists - adverse effects | Lower Urinary Tract Symptoms - physiopathology | Male | Treatment Outcome | 5-alpha Reductase Inhibitors - therapeutic use | Muscarinic Antagonists - therapeutic use | Evidence-Based Medicine | Prostatic Hyperplasia - diagnosis | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | 5-alpha Reductase Inhibitors - adverse effects | Lower Urinary Tract Symptoms - diagnosis | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Phosphodiesterase 5 Inhibitors - therapeutic use | Prostatic Hyperplasia - physiopathology | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Drugs | Medical colleges | Hospitals | Drug therapy, Combination | Drug approval
Journal Article
Journal Article